Lidya Handayani Tjan

Early Differences in Cytokine Production by Severity of Coronavirus Disease 2019

Lidya Handayani Tjan, Koichi Furukawa, Tatsuya Nagano et al. · The Journal of Infectious Diseases · 2021 · 110 citations · Full text

Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine

Koichi Furukawa, Lidya Handayani Tjan, Yukiya Kurahashi et al. · JAMA Network Open · 2022 · 43 citations · Full text

Cross-Neutralizing Activity Against SARS-CoV-2 Variants in COVID-19 Patients: Comparison of 4 Waves of the Pandemic in Japan

Koichi Furukawa, Lidya Handayani Tjan, Silvia Sutandhio et al. · Open Forum Infectious Diseases · 2021 · 23 citations · Full text

Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron’s outbreak

Zhenxiao Ren, Mitsuhiro Nishimura, Lidya Handayani Tjan et al. · PLoS ONE · 2022 · 19 citations · Full text

Seroepidemiological Survey of the Antibody for Severe Acute Respiratory Syndrome Coronavirus 2 with Neutralizing Activity at Hospitals: A Cross-sectional Study in Hyogo Prefecture, Japan

Koichi Furukawa, Jun Arii, Mitsuhiro Nishimura et al. · JMA Journal · 2021 · 16 citations · Full text